AqueSys XEN 45 Glaucoma Implant in Refractory Glaucoma

NACompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

February 29, 2016

Study Completion Date

August 31, 2016

Conditions
GlaucomaGlaucoma, Open Angle
Interventions
DEVICE

AqueSys XEN 45 Glaucoma Implant

Placement of the AqueSys XEN 45 Glaucoma Implant in the study eye

Trial Locations (12)

10003

New York Eye and Ear Infirmary, New York

63110

Washington University in St. Louis, Department of Ophthalmology, St Louis

66213

Stiles Eyecare Excellence & Glaucoma Institute, Overland Park

72704

Vold Vision, Fayetteville

75231

Glaucoma Associates of Texas, Dallas

78229

R and R Eye Research, LLC, San Antonio

80525

Eye Center of Northern Colorado, Fort Collins

85306

George R. Reiss, MD PC, Glendale

90640

Montebello Eye Center, Montebello

92056

San Diego Eye Care Center, Oceanside

94306

Palo Alto Eye Group, Palo Alto

99204

Spokane Eye Clinic, Spokane

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Allergan

INDUSTRY

lead

AqueSys, Inc.

INDUSTRY